Customer Service
PrevistageTM GCC Colorectal Cancer Staging Test
DiagnoCure has granted an exclusive worldwide license for this test which is now offered by Signal Genetics.
Bladder Cancer Test (formerly ImmunoCyt™/uCyt+™)
Diagnocure entered into a product divestment agreement for ImmunoCyt™/uCyt+™ with U.S.-based Scimedx Corporation.